Stock Price & Analysis

Based on the provided data, here's a concise analysis of GL (Globe Life) stock:

Technical Analysis The stock is currently trading at $122.25, down 0.99% in the last session . The RSI-14 at 62.40 indicates moderate bullish momentum without being overbought. The positive MACD of 2.75 suggests an upward trend continuation.

Recent Events & Sentiment

• Truist raised price target to $120 from $105 while maintaining Hold rating, citing Q4 earnings beat and improved 2025 guidance
• Analyst consensus shows Moderate Buy rating with $130.22 price target, indicating 8.54% upside potential
• Concerning insider activity: Multiple insider sales reported recently, including SVP & CAO Michael Shane Henrie selling 3,439 shares (~$421K)

Key Considerations

• Institutional sentiment is mixed with 217 institutions increasing positions while 281 reduced holdings
• Stock appears fairly valued according to multiple analysts [1,2]
• Strong Q4 performance and raised 2025 guidance provide positive fundamental backdrop

Recommendation Based on technical indicators showing moderate bullish momentum but concerning insider selling activity, holding current positions is recommended over initiating new ones at this price level.

Based on the provided data and recent analyst reports, here's a concise prediction for Globe Life (GL) stock in 2025:

GL stock is expected to reach $130.22 by end of 2025, representing an 8.54% upside from current price of $122.25, driven by strong Q4 earnings performance and improved 2025 guidance. However, recent insider selling activity and negative insider sentiment create some downside risks.

The price target is supported by:

1. Truist Financial raised price target to $120 while maintaining Hold rating
2. CFRA maintains Hold rating with $130 target
3. Consensus among analysts is Moderate Buy with $130.22 average target

The S1 support level for GL Stock is $118.45 ,The R1 resistant level for GL Stock is $123.91.

As of the end of day on 2025-02-11, the price of GL Stock was $122.67.

The target price for GL Stock according to analyst rating is 130.22, with the highest price target at 165.00 and the lowest at 110.00. Analysts have a Moderate Buy rating on GL Stock overall.

The market cap of GL is $10.3B.

Based on the provided data and recent market developments, GL appears to be fairly valued at current levels. The company's Q4 2024 performance showed net income of $255 million ($3.01 per share), with strong premium revenue growth but facing some pressure in health underwriting margins. The stock trades at a P/E of 9.34x for Q4 2024, which is relatively reasonable for the insurance sector.

Key Valuation Metrics:

• P/E ratio declined from 11.12x in Q1 2024 to 9.34x in Q4 2024
• EV/EBITDA of 8.12x in Q3 2024 suggests reasonable valuation
• Price-to-Sales ratio of 1.73x in Q4 2024 indicates fair value
• ROE remains healthy at 23.55% in Q3 2024

Recent Developments:

• Truist raised price target to $120 from $105 while maintaining Hold rating
• Analyst consensus shows Moderate Buy with $130.22 price target
• Recent insider selling activity, including SVP & CAO selling 46.7% of holdings

Growth Outlook:

• Management projects 11% EPS growth for 2025 at midpoint of $13.45-$14.05 guidance
• Life premium revenue expected to grow 4.5-5% in 2025
• Health premium revenue projected to increase 7.5-8.5%

The stock appears appropriately valued given its growth prospects and current market conditions, with limited upside potential from current levels.

Globe Life Inc. is an insurance holding company. The Company's primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The Company offers Medicare Supplement and limited-benefit supplemental health insurance products that include accident, cancer, critical illness, heart, and intensive care products. These products are designed to supplement health coverage that applicants already own. Medicare Supplements are offered to enrollees in the traditional fee-for-service Medicare program. Medicare Supplement plans are standardized by federal regulation and are designed to pay deductibles and co-payments not paid by Medicare. It has four segments: life insurance, supplemental health insurance, annuities and investments. Life insurance segment’s products include traditional whole life and term life insurance.

Based on the available data and analyst projections, here are the key predictions for Globe Life (GL) stock price in 2030:

GL stock is projected to reach $175-185 by 2030, driven by consistent earnings growth of 11% annually and favorable mortality trends as indicated in recent earnings reports.

The company's strong agent count growth across divisions (7-11% increase) and strategic expansion plans suggest sustainable revenue growth potential that supports this price target.

However, recent negative insider sentiment with increased share sales by executives and mixed institutional investor movements could create some headwinds for achieving the full upside potential.

GL has a total of 3636 employees.